Leaving the competition behind
Maiden H1 results from Supreme confirm strong progress driven by organic growth, bolt-on...
Read moreAnother leap in scale and outlook still strong
FY21 (to 30 Sept) saw Impax continuing to scale at a pace unmatched by any UK-listed asset manager,...
Read morePoised to recover in 2022
ECO Animal Health’s shares currently stand at a 52-week low, likely on concerns over its exposure...
Read moreInfrastructure & house building powering ahead
UK infrastructure is currently running at c. 40% above pre-pandemic levels (Source: ONS), driven by...
Read moreStrong H1, AUM growth continues post-results
We knew momentum was strong on an absolute basis in H1 22 with AUM reaching £23.4bn on 30 Sep 21,...
Read more
